Navigation Links
NeurogesX Reports Third Quarter 2009 Results
Date:11/6/2009

ctively, based on weighted average shares outstanding of 17.6 million and 17.5 million, respectively.

Cash equivalents and short-term investments were approximately $57.0 million at September 30, 2009, compared to $13.4 million at June 30, 2009. The increase reflects the receipt of a $48.8 million upfront payment from Astellas received in July 2009.

Stephen Ghiglieri, CFO, commented, "The third quarter of 2009 represents the first time we have reported quarterly revenue, which marks a milestone for NeurogesX. Our balance sheet is also strongly positioned with $57 million in cash, cash equivalents and short term investments. Consistent with our spending guidance for 2009, we are continuing our conservative focus in advance of our upcoming PDUFA date. As a result of that focus, we have been investing in commercialization activities that require long lead times, such as setting up the distribution channel, that are necessary to implement now to be ready for our targeted first half 2010 launch. Major investments, such as sales force deployment, are still being deferred pending FDA approval of Qutenza. We are also exploring strategies to further strengthen our balance sheet ahead of a potential U.S. Qutenza launch."

Development Update

NeurogesX is advancing its planning for NGX-1998 and expects to re-initiate clinical development activities in 2010.

Conference Call Details

The Company will hold its quarterly conference call today at 9:00 a.m. ET (6:00 a.m. PT) to discuss third quarter 2009 results.

To participate, please dial 1-877-407-0789 (USA) or 1-201-689-8562 (International). To access the live web cast please visit the Investor Relations section on the corporate web site at http://www.neurogesx.com.

A replay of the conference call will be available beginning November 6, 2009 at 7:30 p.m. ET (4:30 p.m. PT) and endi
'/>"/>

SOURCE NeurogesX
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. NeurogesX to Present at Two November Conferences
2. NeurogesX to Present at UBS Global Life Sciences Conference
3. NeurogesX to Present at Upcoming Fall Conferences
4. NeurogesX Appoints New Board Director and Audit Committee Chairman
5. NeurogesX Reports Second Quarter 2009 Results
6. NeurogesX Announces New PDUFA Date for Qutenza(TM) New Drug Application
7. NeurogesX to Hold Conference Call to Discuss Second Quarter 2009 Financial Results
8. NeurogesX Added to Russell 3000 Index
9. NeurogesX Provides U.S. Regulatory Update for Qutenza(TM)
10. NeurogesX to Present at Needham Life Sciences Conference
11. NeurogesX Receives European Commission Approval for Qutenza(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/19/2014)... 20, 2014 United States Non-Vascular ... GlobalDatas new report, "United States Non-Vascular Stents Market ... the United States Non-Vascular Stents market. The report ... (in units) and average prices (in US dollars) ... Stents and Metal Biliary Stents (Metal Non-Covered Biliary ...
(Date:7/18/2014)... , July 18, 2014  Neogen Corporation (Nasdaq: ... , Neogen,s chief operating officer and president, has resigned, ... work as a consultant going forward on special projects. ... has been in this position since September 2013. On ... James Herbert , who has been Neogen,s chief ...
(Date:7/18/2014)... world is mostly neutral. That is, most of ... The number of electrons in the outer parts of ... of atoms. As one or more electrons are ... a much stronger positive pull from the nucleus. ... size, ensures that those electrons are less vulnerable to ...
(Date:7/18/2014)... 2014  Neurotrope, Inc. (OTCQB: NTRP) today announced that ... Co-Chairmen Charles S. Ramat and Paul ... basis, effective immediately. Messrs. Ramat and Freiman replace Dr. ... Executive Officer of Neurotrope Bioscience, Inc., (a wholly-owned subsidiary ... agreement with Neurotrope Bioscience Inc. terminated as of July ...
Breaking Biology Technology:United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 2United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 3United States Non-Vascular Stents Market Outlook to 2020 | Researchmoz 4Highly charged ions 2Highly charged ions 3Highly charged ions 4Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 2Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 3Neurotrope Board of Directors Appoints Chairmen Ramat and Freiman as Interim Co-CEOs 4
... FRANCISCO, CA November 20, 2007 Acclaimed stem cell ... he and his Kyoto University colleagues have successfully reprogrammed ... (ES) cells. Because it circumvents much of the ... from human embryos, this breakthrough, reported in the journal ...
... Nov. 20 China Biopharma,Inc. (OTC Bulletin Board: ... take closer control and to better improve its ... away from the increasingly competitive and,low margin vaccine ... "We plan to take more control on the ...
... 20 ,Exelixis, Inc. (Nasdaq: EXEL ) today ... Taconic Farms, Inc. (Hudson, NY) pursuant to which ... Artemis Pharmaceuticals GmbH,for approximately $20 million, subject to ... research, development and commercialization of,genetically engineered mouse models ...
Cached Biology Technology:Shinya Yamanaka reprograms human adult cells 2China Biopharma, Inc. Announces New Plan of Operation 2Exelixis Sells 80% Stake in Artemis to Taconic 2Exelixis Sells 80% Stake in Artemis to Taconic 3Exelixis Sells 80% Stake in Artemis to Taconic 4
(Date:7/21/2014)... RUSTON, La. Dr. Mark DeCoster, the James ... at Louisiana Tech University, will present as an ... 24-25 at the Biopolis Research and Development Center ... research faculty member in Louisiana Tech,s Institute for ... for 2D and 3D cell and tissue models." ...
(Date:7/21/2014)... of California, Riverside Bourns College of Engineering students have designed ... backyard grill reduces by 70 percent the level of a ... steel carbon plate with an insulated handle can be installed ... grill to allow the plate to slide in and out. ... could sell new grills with the plate already installed. , ...
(Date:7/21/2014)... Terra and Aqua satellites detected 154 hotspots in areas ... and land fires had increased again following a decline ... Sunday,s report was far higher than what had been ... spots. , The hotspots were scattered in six regencies ... coastal areas. Smoke and the related haze it creates ...
Breaking Biology News(10 mins):Louisiana Tech University professor presents at International Bioprinting Congress 2Catching grease to cut grill pollution 2
... might find it progressively harder to navigate the maze of ... short-term exposure to vehicle pollution, mice showed significant brain damage ... The mind-numbing toxin is not an exhaust gas, but ... and weathering of car parts and pavement, according to the ...
... A groundbreaking clinical study of a new method for preventing ... the medical journal Ultrasound in Obstetrics & Gynecology , ... ( The peer-reviewed findings were led by the Perinatology ... the Wayne State University School of Medicine at Hutzel Hospital ...
... (April 6, 2011) -- Most people experience X-ray computed tomography (CT) ... clot. But in the lab of Dr. Quin Liu, PhD., in ... of CT scanners as part of an agriculture study to increase ... went little potted rice plants in an automated facility that could ...
Cached Biology News:Freeway air bad for mouse brain 2Major breakthrough in preventing premature birth announced by NIH/WSU 2Major breakthrough in preventing premature birth announced by NIH/WSU 3Seeing rice with X-rays may improve crop yields 2
The imaging screen-K (Kodak), is a 35 x 43 cm storage phosphor screen that is used for the quantitation and imaging of 32P, 33P, 35S, 14C, and 3H....
The optional fixed lens, 105 mm, is for use with the VersaDoc imaging systems for imaging small samples at high resolution....
The filter 695RDF55 Reflect 635 for the Molecular Imager FX is a band pass filter for Cy5 and Alexa Fluor 635 dyes....
The HQ505, 20 OptiGreen filter for the Molecular Imager FX is a band pass filter used for detection of Cy2 and FITC with 532 nm excitation....
Biology Products: